Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value: $2.338B (100.0% shares, 0.0% debt)

Holdings (36)

ABIOMED INC 16.8%
Value $392M Shares 1,346,660 Est. Cost $32.04 Unrealized
CLOVIS ONCOLOGY INC 8.9%
Value $209M Shares 3,955,660 Est. Cost $54.18 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 8.8%
Value $206M Shares 2,545,482 Est. Cost $79.79 Unrealized +7.6%
UTHR UNITED THERAPEUTICS CORP DEL 7.8%
Value $182M Shares 1,622,631 Est. Cost $88.73 Unrealized +43.2%
INSM INSMED INC 6.9%
Value $161M Shares 7,159,590 Est. Cost $16.67 Unrealized +57.8%
SAGE THERAPEUTICS INC 5.6%
Value $132M Shares 818,331 Est. Cost $46.14 Unrealized
ALEXION PHARMACEUTICALS INC 5.4%
Value $127M Shares 1,135,845 Est. Cost $120.92 Unrealized
EPIZYME INC 5.2%
Value $122M Shares 6,895,075 Est. Cost $15.12 Unrealized
FOLD AMICUS THERAPEUTICS INC 4.0%
Value $92.46M Shares 6,147,829 Est. Cost $6.44 Unrealized +136.3%
IMMUNOMEDICS INC 3.0%
Value $70.07M Shares 4,796,008 Est. Cost $11.54 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.0%
Value $70.02M Shares 4,155,670 Est. Cost $8.70 Unrealized +92.3%
AMAG PHARMACEUTICALS INC 2.9%
Value $67.32M Shares 3,340,806 Est. Cost $29.37 Unrealized
ALGN ALIGN TECHNOLOGY INC 2.3%
Value $54.92M Shares 218,707 Est. Cost $98.66 Unrealized +160.3%
WRIGHT MED GROUP N V 2.3%
Value $54.61M Shares 2,752,294 Est. Cost $23.42 Unrealized
STAA STAAR SURGICAL CO 2.2%
Value $52.03M Shares 3,515,385 Est. Cost $8.00 Unrealized +95.2%
KARYOPHARM THERAPEUTICS INC 2.1%
Value $49.38M Shares 3,679,978 Est. Cost $19.34 Unrealized
AIMMUNE THERAPEUTICS INC 1.8%
Value $43.18M Shares 1,356,514 Est. Cost $23.73 Unrealized
PRTA PROTHENA CORP PLC 1.7%
Value $40.43M Shares 1,101,338 Est. Cost $32.98 Unrealized +10.3%
ACAD ACADIA PHARMACEUTICALS INC 1.6%
Value $37.09M Shares 1,650,780 Est. Cost $29.82 Unrealized -7.2%
CELGENE CORP 1.4%
Value $33.82M Shares 379,140 Est. Cost $96.18 Unrealized
MOMENTA PHARMACEUTICALS INC 1.4%
Value $33.22M Shares 1,830,435 Est. Cost $14.12 Unrealized
SHIRE PLC 1.2%
Value $28.56M Shares 191,200 Est. Cost $197.13 Unrealized
ALDER BIOPHARMACEUTICALS INC 1.0%
Value $23.49M Shares 1,849,832 Est. Cost $11.48 Unrealized
RIGEL PHARMACEUTICALS INC 0.6%
Value $14.04M Shares 3,966,087 Est. Cost $3.40 Unrealized
GILD GILEAD SCIENCES INC 0.6%
Value $13.26M Shares 175,900 Est. Cost $62.02 Unrealized -5.0%
EXAS EXACT SCIENCES CORP 0.5%
Value $12.61M Shares 312,719 Est. Cost $13.61 Unrealized +258.3%
DICERNA PHARMACEUTICALS INC 0.2%
Value $4.789M Shares 500,913 Est. Cost $5.39 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value $3.162M Shares 1,162,473 Est. Cost $4.37 Unrealized
ALIMERA SCIENCES INC 0.1%
Value $3.104M Shares 3,013,793 Est. Cost $4.88 Unrealized
ZOGENIX INC 0.1%
Value $1.181M Shares 29,500 Est. Cost $13.36 Unrealized
IDERA PHARMACEUTICALS INC 0.0%
Value $1.134M Shares 616,355 Est. Cost $3.70 Unrealized
CYTK CYTOKINETICS INC 0.0%
Value $891K Shares 123,686 Est. Cost $6.71 Unrealized +27.7%
HISTOGENICS CORP 0.0%
Value $833K Shares 302,922 Est. Cost $11.00 Unrealized
TREVENA INC 0.0%
Value $560K Shares 341,300 Est. Cost $2.30 Unrealized
SOPHIRIS BIO INC 0.0%
Value $496K Shares 247,000 Est. Cost $2.60 Unrealized
MELINTA THERAPEUTICS INC 0.0%
Value $375K Shares 50,689 Est. Cost $15.80 Unrealized